首页|探究甲硝唑片联合克林霉素磷酸酯阴道凝胶治疗细菌性阴道炎的效果

探究甲硝唑片联合克林霉素磷酸酯阴道凝胶治疗细菌性阴道炎的效果

扫码查看
目的 分析甲硝唑片联合克林霉素磷酸酯阴道凝胶治疗细菌性阴道炎的效果.方法 选取60例细菌性阴道炎患者作为研究对象,采用随机数字表法将其分为对照组和观察组,各30例.对照组接受克林霉素磷酸酯阴道凝胶治疗,观察组接受甲硝唑片联合克林霉素磷酸酯阴道凝胶治疗.比较两组患者治疗效果、症状消失时间、症状积分、炎性因子指标、阴道免疫细胞指标、复发率、不良反应发生率.结果 观察组治疗总有效率93.33% 高于对照组的66.67%,差异有统计学意义(P<0.05).观察组阴道疼痛、外阴瘙痒、白带减少消失时间分别为(3.11±0.25)、(3.65±0.25)、(4.05±0.25)d,均短于对照组的(5.21±0.21)、(5.68±0.12)、(6.68±0.34)d,差异有统计学意义(P<0.05).治疗后,两组患者症状积分均低于本组治疗前,且观察组症状积分(9.54±1.21)分低于对照组的(12.68±1.24)分,差异有统计学意义(P<0.05).治疗后,观察组白细胞介素-6(IL-6)、白细胞介素-4(IL-4)、C反应蛋白(CRP)分别为(51.28±1.21)pg/ml、(62.35±1.65)ng/ml、(2.51±0.35)mg/dl,低于对照组的(70.54±1.23)pg/ml、(86.54±1.52)ng/ml、(3.98±0.42)mg/dl,差异有统计学意义(P<0.05).治疗后,观察组 γ 干扰素(IFN-γ)(65.25±1.21)pg/ml、白细胞介素-12(IL-12)(200.51±10.65)pg/ml均低于对照组的(74.69±1.65)、(220.25±6.38)pg/ml,差异有统计学意义(P<0.05).随访3个月,观察组复发率3.33% 低于对照组的30.00%,差异有统计学意义(P<0.05).观察组不良反应发生率6.67% 略低于对照组的10.00%,但无明显差异(P>0.05).结论 临床治疗细菌性阴道炎可在克林霉素磷酸酯阴道凝胶基础上联用甲硝唑片,能更好地控制机体炎性反应,提升阴道免疫细胞功能,促进症状缓解,疗效理想,且能进一步降低疾病复发几率.
The effect of metronidazole tablets combined with clindamycin phosphate vaginal gel on bacterial vaginitis
Objective To analyze the effect of metronidazole tablets combined with clindamycin phosphate vaginal gel on bacterial vaginitis. Methods 60 cases of bacterial vaginitis patients were selected as the study subjects,and they were divided into the control group and the observation group using the random numerical table,with 30 cases in each group. The control group received clindamycin phosphate vaginal gel treatment,and the observation group received metronidazole tablets combined with clindamycin phosphate vaginal gel treatment. The treatment effect,symptom disappearance time,symptom score,inflammatory factors,vaginal immune cell indicators,recurrence rate,and incidence of adverse reactions were compared between the two groups. Results The total effective rate of 93.33% in the observation group was higher than 66.67% in the control group,and the difference was statistically significant (P<0.05). The disappearance time of vaginal pain,vulvar pruritus and leukorrhea reduction were (3.11±0.25),(3.65±0.25) and (4.05±0.25) d in the observation group,which were shorter than (5.21±0.21),(5.68±0.12) and (6.68±0.34) d in the control group. The difference was statistically significant (P<0.05). After treatment,the symptom scores in both groups were lower than those before treatment in this group,and the symptom score of (9.54±1.21) points in the observation group was lower than (12.68±1.24) points in the control group. The difference was statistically significant (P<0.05). After treatment,interleukin-6 (IL-6),interleukin-4 (IL-4),and C-reactive protein (CRP) of the observation group were (51.28±1.21) pg/ml,(62.35±1.65) ng/ml,and (2.51±0.35) mg/dl,which were lower than (70.54±1.23) pg/ml,(86.54±1.52) ng/ml,and (3.98±0.42) mg/dl in the control group,and the difference was statistically significant (P<0.05). After treatment,the observation group had γ-interferon (IFN-γ) of (65.25±1.21) pg/ml and interleukin-12 (IL-12) of (200.51±10.65) pg/ml,which were lower than (74.69±1.65) and (220.25±6.38) pg/ml in the control group,and the difference was statistically significant (P<0.05). At 3-month follow-up,the recurrence rate of 3.33% in the observation group was lower than 30.00% in the control group,and the difference was statistically significant (P<0.05). The incidence rate of adverse reactions of 6.67% in the observation group was slightly lower than 10.00% in the control group,but the difference was not statistically significant (P>0.05). Conclusion Clinical treatment of bacterial vaginitis can be combined with metronidazole tablets on the basis of clindamycin phosphate vaginal gel,which can better control the body's inflammatory reaction,enhance the function of the vaginal immune cells,and promote symptom relief. This method has ideal efficacy,and can further reduce the chances of disease recurrence.

Bacterial vaginitisClindamycin phosphate vaginal gelMetronidazole tabletsInflammatory reactionImmune cell functionRecurrence

刘娟、范芳、汤吉琴

展开 >

344000 抚州市临川区人民医院妇产科

细菌性阴道炎 克林霉素磷酸酯阴道凝胶 甲硝唑片 炎性反应 免疫细胞功能 复发

2024

中国实用医药
中国康复医学会

中国实用医药

影响因子:0.797
ISSN:1673-7555
年,卷(期):2024.19(23)